| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ASO | Common Stock | Options Exercise | +1,990 | +2.3% | 86,880 | 30 Jan 2025 | Direct | F1, F2 | ||
| transaction | ASO | Common Stock | Tax liability | $30,223 | -560 | -0.64% | $53.97 | 86,320 | 30 Jan 2025 | Direct | |
| transaction | ASO | Common Stock | Options Exercise | +2,751 | +3.2% | 89,071 | 31 Jan 2025 | Direct | F1 | ||
| transaction | ASO | Common Stock | Tax liability | $36,636 | -670 | -0.75% | $54.68 | 88,401 | 31 Jan 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ASO | Restricted Stock Units | Options Exercise | $0 | -1,990 | -44% | $0.000000 | 2,531 | 30 Jan 2025 | Common Stock | 1,990 | Direct | F1, F3, F4 | |
| transaction | ASO | Restricted Stock Units | Options Exercise | $0 | -2,751 | -100% | $0.000000 | 0 | 31 Jan 2025 | Common Stock | 2,751 | Direct | F1, F3, F5 |
| Id | Content |
|---|---|
| F1 | Restricted stock units convert into common stock on a one-for-one basis. |
| F2 | Includes shares of Common Stock acquired under the Issuer's employee stock purchase plan. |
| F3 | Granted under the Company's 2020 Omnibus Incentive Plan. |
| F4 | On March 30, 2022, the Reporting Person was granted 8,501 performance-based restricted stock units ("PRSUs"). These PRSUs vest if certain performance criteria and/or Issuer stock price conditions are met and certified by the Issuer's compensation committee. On March 1, 2023, the Issuer's compensation committee certified achievement of 93.7% of the performance criteria during fiscal 2022 meaning that 7,961 PRSUs were deemed earned. Of this earned amount, 25% of the earned amount of this grant vested on March 1, 2023, and the remaining 75% will vest in three equal annual installments beginning on January 30, 2024, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. The remaining unearned amount of this grant (i.e., 540 PRSUs) may vest upon certification by the Issuer's compensation committee of achievement of certain Issuer stock price conditions as of January 30, 2026. |
| F5 | On March 31, 2021, the Reporting Person was granted 11,004 PRSUs. These PRSUs vest if certain performance criteria and/or Issuer stock price conditions are met and certified by the Issuer's compensation committee. Following certification of achievement of the performance criteria during fiscal 2021 by the Issuer's compensation committee on March 2, 2022, 25% of this grant vested on March 2, 2022, and the remaining 75% vest in three equal annual installments beginning on January 31, 2023, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. |